Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONSUL: Celecoxib + Golimumab vs Golimumab in Ankylosing Spondylitis
NCT02758782Phase 4Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Sep 2016
- Primary completion
- Jan 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of celecoxib in ankylosing spondylitis (AS), sponsored by Charité – Universitätsmedizin Berlin. Started Sep 2016; status: completed.
02
Drugs
celecoxib
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT02758782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02758782.